Nateglinide - CAS 105816-04-4
Catalog number:
105816-04-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H27NO3
Molecular Weight:
317.42
COA:
Inquire
Targets:
Others
Description:
Nateglinide(Starlix) is an insulin secretagog agent that lowers blood glucose levels by stimulating insulin secretion from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the β cells.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
A-4166
MSDS:
Inquire
1.Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.
Tostes GC1, Cunha MR1, Fukui RT1, Correia MR1, Rocha DM1, Dos Santos RF1, da Silva ME1. Diabetol Metab Syndr. 2016 Jan 4;8:1. doi: 10.1186/s13098-015-0120-6. eCollection 2016.
BACKGROUND: To compare the effects of nateglinide and rosiglitazone on inflammatory markers, GLP-1 levels and metabolic profile in patients with type 2 diabetes (DM2).
2.Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naïve Japanese patients with type 2 diabetes mellitus: A pilot study.
Tanimoto M1, Kanazawa A2, Hirose T1, Yoshihara T1, Kobayashi-Kimura S1, Nakanishi R1, Tosaka Y1, Sasaki-Omote R1, Kudo-Fujimaki K1, Komiya K1, Ikeda F1, Someya Y1, Mita T1, Fujitani Y1, Watada H3. J Diabetes Investig. 2015 Sep;6(5):560-6. doi: 10.1111/jdi.12338. Epub 2015 Mar 15.
AIMS/INTRODUCTION: Dipeptidyl peptidase-4 inhibitors and glinides are effective in reducing postprandial hyperglycemia. However, little information is available on the comparative effects of the two drugs on the levels of postprandial glucose. The aim of the present study was to compare the effects of sitagliptin and nateglinide on meal tolerance tests in drug-naïve patients with type 2 diabetes mellitus.
3.Preparation of polyclonal antibodies for nateglinide (NTG) and development of a sensitive chemiluminescent immunoassay to detect NTG in tablets and serum.
Zheng L1, Wang J1, Zhang J2, Song Z1, Dong Y1, Wang Y1, Tong Z2, Deng C3, Yin Y1, Meng M4, Xi R1. Talanta. 2016 Jan 1;146:483-9. doi: 10.1016/j.talanta.2015.09.008. Epub 2015 Sep 9.
In this study, we prepared polyclonal antibodies against anti-diabetic drug nateglinide (NTG), and established a sensitive chemiluminescent immunoassay (CLIA) to detect NTG in tablets and serum. Two kinds of immunogens were synthesized using ethylcarbodiimide (EDC)/hydroxysuccinimide (NHS) and carbonyldiimidazole (CDI)/4-dimethylaminopyridine (DMAP) as coupling reagents respectively. When activated by EDC/NHS, more molecules of NTG coupled with carrier protein in immunogens. A horseradish peroxidase (HRP)-luminol-H2O2 system with p-iodophenol enhancement was applied in the CLIA analysis. The antibodies in EDC/NHS group showed higher titer, sensitivity and wider detection linear range than those in CDI/DMAP group, and were chosen for next studies. The developed CLIA assay exhibited good selectivity towards NTG among structually similar analogs. The method could detect as low as 0.35 ng mL(-1) NTG in buffer, 2.1 ng mL(-1) NTG in serum and 0.
4.Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide-maltodextrin complex.
Sahoo RK1, Biswas N1, Guha A1, Sahoo N1, Kuotsu K1. Acta Pharm Sin B. 2014 Oct;4(5):408-16. doi: 10.1016/j.apsb.2014.08.001. Epub 2014 Sep 4.
The aim of this study was to characterize the provesicle formulation of nateglinide (NTG) to facilitate the development of a novel controlled release system of NTG with improved efficacy and oral bioavailability compared to the currently marketed NTG formulation (Glinate™ 60). NTG provesicles were prepared by a slurry method using the non-ionic surfactant, Span 60 (SP), and cholesterol (CH) as vesicle forming agents and maltodextrin as a coated carrier. Multilamellar niosomes with narrow size distribution were shown to be successfully prepared by means of dynamic laser scattering (DLS) and field emission scanning electron microscopy (FESEM). The absence of drug-excipient interactions was confirmed by Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC) and X-ray diffraction (XRD) studies. In vitro release of NTG in different dissolution media was improved compared to pure drug. A goat intestinal permeation study revealed that the provesicular formulation (F4) with an SP:CH ratio of 5:5 gave higher cumulative amount of drug permeated at 48 h compared to Glinate™ 60 and control.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 143984-17-2 Y-29794 Tosylate

Y-29794 Tosylate
(CAS: 143984-17-2)

Y-29794 is an orally active, potent and specific non-peptide inhibitor of prolyl endopeptidase, a serine peptidase that may be implicated in the biosynthesis of...

CAS 84676-89-1 Astragaloside II

Astragaloside II
(CAS: 84676-89-1)

Astragaloside II is a saponin found in the root of Astragalus membranaceus (Fisch.) Bunge, which is known as huáng qí in Traditional Chinese Medicine. It has ca...

CAS 40957-83-3 Glycitein

Glycitein
(CAS: 40957-83-3)

Glycitein is a soybean (yellow cultivar) isoflavonoid. It may be used to study anti-oxidation processes at the level of gene transcription where it increases th...

CFI-401870
(CAS: 1599460-95-3)

CFI-401870, an azabicyclo derivative, has been found to be a TTK inhibitor that could be significant in anticancer studies. IC50 < 10 nM.

CAS 894-71-3 Nortriptyline hydrochloride

Nortriptyline hydrochloride
(CAS: 894-71-3)

Nortriptyline hydrochloride is a second-generation tricyclic antidepressant (TCA) marketed as the hydrochloride salt under the trade names Sensoval, Aventyl and...

Sonoflora 1
(CAS: 1609250-37-4)

Sonoflora 1, a kind of PDT photosensitivizer, was once studied against breast cancer and the Phase I/II trial has been already discontinued by SonneMed.

CAS 1579991-61-9 Chitinase-IN-1

Chitinase-IN-1
(CAS: 1579991-61-9)

Chitinase-IN-1 is a insect chitinase and N- acetyl hexosaminidase inhibitor and pesticide; 50 uM/20uM compound concentration&#39;s inhibitory percentage are 75%...

CAS 105816-04-4 Nateglinide

Nateglinide
(CAS: 105816-04-4)

Nateglinide(Starlix) is an insulin secretagog agent that lowers blood glucose levels by stimulating insulin secretion from the pancreas. It achieves this by clo...

CAS 329216-63-9 Quetiapine metabolite Quetiapine sulfoxide

Quetiapine metabolite Quetiapine sulfoxi
(CAS: 329216-63-9)

Quetiapine metabolite Quetiapine sulfoxide, a metabolite of Quetiapine, has antipsychotic effect.

PD-116152
(CAS: 101708-64-9)

PD-116152 is a novel and highly substituted phenazine. It has antitumor activity. It was isolated from the culture broth of a Streptomyces sp.

CAS 480-11-5 Oroxylin A

Oroxylin A
(CAS: 480-11-5)

Oroxylin A possessed abilities of inhibiting the ATRA-induced IL-6 production via modulation of LAP/LIP/CHOP in leukemia cell lines, which could providing a the...

CAS 263707-16-0 ESI-09

ESI-09
(CAS: 263707-16-0)

ESI-09 is a specific exchange protein directly activated by cAMP (EPAC) inhibitor with IC50 of 3.2 μM and 1.4 μM for EPAC1 and EPAC2, respectively, >100-fold se...

CAS 434-13-9 Lithocholic acid

Lithocholic acid
(CAS: 434-13-9)

Lithocholic acid is a toxic secondary bile acid, causes intrahepatic cholestasis, has tumor-promoting activity, its toxic effect can be protected after it activ...

CAS 58-15-1 Amidopyrine

Amidopyrine
(CAS: 58-15-1)

Aminophenazone (or aminopyrine) is a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis.

NSC659000
(CAS: 139449-81-3)

NSC659000 is a potential antifungal agent. It is one of the 3-(3-methyl-5-isoxazolyl)-2-styrylquinazolin-4(3H)-ones derivatives that be synthesized for antifung...

CAS 16789-98-3 Desmopressin acetate

Desmopressin acetate
(CAS: 16789-98-3)

Desmopressin acetate, also know as DDAVP, has been found to be a vasopressor agent that could exhibit antidiuretic activity and probably be useful in improving ...

CAS 1015474-32-4 CC122

CC122
(CAS: 1015474-32-4)

CC122 is a novel agent for DLBCL. It is an orally available pleiotropic pathway modulator. It has antitumor and immunomodulatory activity. It is used for the tr...

CAS 3734-80-3 Ocaphane

Ocaphane
(CAS: 3734-80-3)

Ocaphane is a strong antitumor agent used on a number of animal tumors along with fairly toxic to hemopoietic organs.

CAS 420126-30-3 Antitumor Compound 1

Antitumor Compound 1
(CAS: 420126-30-3)

Antitumor Compound 1 is a potent compound which comprises a new imidazopyridine having excellent antitumor activity as an active ingredient.

BPTES
(CAS: 314045-39-1)

BPTES is a potent and selective Glutaminase GLS1 (KGA) inhibitor with IC50 of 0.16 μM.

Chemical Structure

CAS 105816-04-4 Nateglinide

Quick Inquiry

Verification code

Featured Items